Bernstein, David I <br/><br/>
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.  [electronic resource] 

 -  Vaccine  Dec 2009 
 - 484-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2009.09.135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Neutralizing--immunology<br/>Antibody Formation--immunology<br/>Antigens, Viral--immunology<br/>Cytomegalovirus--immunology<br/>Cytomegalovirus Vaccines--administration & dosage<br/>Double-Blind Method<br/>Flow Cytometry<br/>Humans<br/>Immunity, Cellular--immunology<br/>Middle Aged<br/>Models, Biological<br/>T-Lymphocytes--immunology<br/>Young Adult